Iron Deficiency Anaemia in Adults: Oral and Intravenous Iron Therapy Treatment (662)

Warning

exp date isn't null, but text field is

Abstract

This guideline focuses on the diagnosis and treatment of iron deficiency anaemia (IDA) in adult patients (16 years and
over) in acute and primary care settings. The treatment of IDA is covered to include the place of oral and intravenous
(IV) iron replacement therapy.

For the purpose of the guideline the following clinical situations are not covered:
• pregnancy,
• postpartum anaemia,
• surgery/trauma,
• paediatrics (<16 years),
• patients with chronic kidney disease (CKD) stages 4-5.

Resources

Use the button below to access this resource item.

Access this resource

Last reviewed: 11 May 2022

Next review: 01 May 2025

Author(s): Laura Maguire

Version: 3

Approved By: Medicines Utilisation Subcommittee of ADTC

Document Id: 662